Allergan to Buy SkinMedica Skin Care Business for $350 Million

Allergan (NYSE: AGN  ) has entered into a definitive agreement to purchase the "topical aesthetics" skin care business of privately held SkinMedica. The business in question, which does not include SkinMedica's Colorescience line of make-ups, focuses on sales of prescription and non-prescription skin care products generally sold by doctors.

Allergan describes the acquisition as complementary to its existing product lines, the most famous of which is probably Botox. It also has Juvederm and Latisse. Allergan will pay SkinMedica $350 million immediately, with an additional $25 million to be paid if the business hits certain sales targets.

While privately held SkinMedica does not break down its financial information publicly by product line, annual sales of the company as a whole are estimated to be in the range of $69 million.

Read/Post Comments (0) | Recommend This Article (0)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2117154, ~/Articles/ArticleHandler.aspx, 8/26/2016 9:55:38 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 39 minutes ago Sponsored by:
DOW 18,395.40 -53.01 -0.29%
S&P 500 2,169.04 -3.43 -0.16%
NASD 5,218.92 6.71 0.13%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
AGN.DL $0.00 Down +0.00 +0.00%
Allergan CAPS Rating: ****